Skip to main content
Cell TherapyIndustry

Ep. 100: “State of CIRM” Featuring Kevin McCormack

By September 12, 2017March 30th, 2023No Comments

Guest:

For the interview portion of the show of our 100th episode, we welcome Kevin McCormack from the California Institute of Regenerative Medicine, or CIRM, to talk about all of CIRM’s progress, past, present, and future…CIRM was created in 2004 to translate stem cell discoveries into therapies, and we will talk to Kevin about the progress this funding has made.

Featured Resource: mTeSR™1 cGMP, Feeder-Free Maintenance Medium for Human ES and iPS Cells

Resources and Links

First Hurricane Harvey, Now Irma: Is Climate Change to Blame for Destructive Storms? – The connection between climate change and hurricanes is to say that climate change doesn’t cause individual storms, but it can make them stronger than they would have been otherwise.

Multicohort Analysis Reveals Baseline Transcriptional Predictors of Influenza Vaccination Responses – A set of nine genes can signal whether a young adult will develop a strong response to the flu vaccine.

Zika Virus Has Oncolytic Activity Against Glioblastoma Stem Cells – Zika virus can infect and kill stem cells in human glioblastoma tissue, without infecting healthy brain cells.

Human iPS Cell-Derived Dopaminergic Neurons Function in a Primate Parkinson’s Disease Model – The Jun Takahashi lab shows monkeys with Parkinson’s disease symptoms show significant improvement over two years after being transplanted neurons prepared from human iPS cells.

Photo Reference: Courtesy of Kevin McCormack

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe